# Primary Immunodeficiency studies recruiting: 23 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials that are observational for Primary Immunodeficiency Diseases that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Primary Immunodeficiency Diseases studies: 23 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/primary-immunodeficiency-diseases

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 23
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 23, 2026 | NCT07837518 | Knowledge of Inborn Errors of Immunity Among Pediatric Physicians | Assiut University | Observational | Not yet recruiting | Primary Immunodeficiency Diseases | 347 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837518) |
| April 13, 2026 | NCT07526714 | Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies | Central Hospital, Nancy, France | Observational | Not yet recruiting | Primary Immune Deficiencies, Benign Lymphoproliferative Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526714) |
| April 7, 2026 | NCT07516002 | Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency | Peking University People's Hospital | Observational | Not yet recruiting | Primary Immunodeficiency Diseases | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07516002) |
| December 3, 2025 | NCT07262047 | Quality of Life Among Children With Inborn Error of Immunity | Sohag University | Observational | Not yet recruiting | Primary Immunodeficiency | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07262047) |
| May 31, 2025 | NCT06999954 | Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform | Shwachman-Diamond Syndrome Alliance Inc | Observational | Recruiting | Shwachman-Diamond Syndrome, SDS, IBMF, Congenital Neutropenia, Heme Malignancy, Shwachman Syndrome, Inherited Bone... | 8,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06999954) |
| November 1, 2024 | NCT06669949 | Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) | University of California, San Francisco | Observational | Recruiting | Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06669949) |
| August 21, 2024 | NCT06565078 | A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency | Takeda | Observational | Recruiting | Primary Immunodeficiency Diseases (PID) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06565078) |
| July 25, 2024 | NCT06519734 | Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Primary Immune Deficiency Diseases | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06519734) |
| December 13, 2023 | NCT06169150 | Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Nervous System Disease, Immune System Disease | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06169150) |
| April 29, 2021 | NCT04864886 | Metabolic Profiling of Immune Responses in Immune-mediated Diseases | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Primary Immunodeficiency, Psoriasis, Atopic Dermatitis, Immune-mediated Diseases | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04864886) |
| March 5, 2021 | NCT04784364 | Biologics And Clinical Immunology Cohort at Sinai | Icahn School of Medicine at Mount Sinai | Observational | Recruiting | Immunological Disease, Autoimmune Diseases, Primary Immune Deficiency | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04784364) |
| August 27, 2020 | NCT04528355 | Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC | Sponsor not shown (see the record) | Observational | Recruiting | Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04528355) |
| July 7, 2020 | NCT04459689 | COVID-19 in PID Survey | Imagine Institute | Observational | Recruiting | Primary Immune Deficiency, COVID | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04459689) |
| February 21, 2020 | NCT04280510 | Pathogenic Study of Adult Immune Enteropathies | Institut National de la Santé Et de la Recherche Médicale, France | Observational | Recruiting | Celiac Disease, Autoimmune Enteropathy, Inflammatory Bowel Diseases | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04280510) |
| August 1, 2018 | NCT03610802 | Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Primary Immunodeficiency | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03610802) |
| February 6, 2018 | NCT03422614 | Pathophysiology of Inborn Immunodeficiencies | University of Zurich | Observational | Recruiting | Primary Immune Deficiency Disorder | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03422614) |
| January 9, 2018 | NCT03394053 | The Mechanistic Biology of Primary Immunodeficiency Disorders | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Primary Immunodeficiency Disorders | 1,190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03394053) |
| July 2, 2017 | NCT03206099 | NIAID Centralized Sequencing Protocol | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Atopy, Primary Immunodeficiency, Autoimmunity, Autoinflammation | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03206099) |
| April 13, 2016 | NCT02735824 | Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies | University Children's Hospital, Zurich | Observational | Recruiting | Immunologic Deficiency Syndromes, Primary Immune Deficiency (PID) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02735824) |
| October 18, 2010 | NCT01222741 | Studies of Disorders With Increased Susceptibility to Fungal Infections | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Fungal Infections, Primary Immune Deficiencies | 850 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01222741) |
| November 29, 2006 | NCT00404560 | Detection and Characterization of Infections and Infection Susceptibility | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Immune Deficiencies | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00404560) |
| October 31, 2005 | NCT00246857 | Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Primary Immune Deficiency | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00246857) |
| November 4, 1999 | NCT00001467 | Genetic Analysis of Immune Disorders | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | DOK 8, STAT1, GATA2, Immunodeficiency, STAT3 | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00001467) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| University of Zurich | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Shwachman-Diamond Syndrome Alliance Inc | 1 |
| University Children's Hospital, Zurich | 1 |
| University of California, San Francisco | 1 |
| Imagine Institute | 1 |
| Central Hospital, Nancy, France | 1 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 1 |
| Sohag University | 1 |
| Peking University People's Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 13 |
| France | 3 |
| Switzerland | 2 |
| Turkey (Türkiye) | 2 |
| Japan | 1 |
| Taiwan | 1 |
| Italy | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Water delivery companies in the United States](https://specstream.ai/data/businesses/water-delivery-companies/united-states)
- [B2B international trade companies in the United States](https://specstream.ai/data/businesses/b2b-international-trade-companies/united-states)
- [Certification bodies in the United States](https://specstream.ai/data/businesses/certification-bodies/united-states)
- [Eastern European restaurants in the United States](https://specstream.ai/data/businesses/eastern-european-restaurants/united-states)
- [Georgian restaurants in the United States](https://specstream.ai/data/businesses/georgian-restaurants/united-states)
- [Jewelry manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-manufacturers/united-states)
